----- 细胞毒素和免疫毒素:用于癌症治疗的临床应用
Preface: An Overview of Immunotoxins and Cytotoxins in Clinical Trials PART 1. PSEUDOMONAS EXOTOXIN (PE)-BASED IMMUNOTOXINS/CYTOTOXINS Targeting of Pseudomonas Exotoxin-based Immunotoxins to Hematologic Malignancies, Robert J. Kreitman Interleukin-4-targeted Cytotoxin for Recurrent Glioblastoma Therapy, Koji Kawakami, Mariko Kawakami, Robert J. Kreitman, and Raj K. Puri Interleukin-13 Receptors and Development of IL-13-Pseudomonas Exotoxin for Human Cancer Therapy, Bharat H. Joshi, Syed R. Husain, Pamela Leland, and Raj K. Puri PART 2. RICIN-BASED IMMUNOTOXINS/CYTOTOXINS Ricin Immunotoxins in Lymphomas, Ronald Schnell and Andreas Engert PART 3. DIPHTHERIA TOXIN (DT)-BASED IMMUNOTOXINS/CYTOTOXINS Diphtheria-based Immunotoxins: Targeting Overexpressed Interleukin-13 Receptor and Urokinase-type Plasminogen Activator Receptor on Glioblastoma Multiforme, Edward Rustamzadeh, Walter A. Hall, Deborah Todhunter, and Daniel Vallera DAB389IL-2 (Ontak): Development and Therapeutic Applications, Paul J. Shaughnessy, and Charles F. LeMaistre Transferrin Diphtheria Toxin for Brain Tumor Therapy, Simon Long and Patrick Rossi GM-CSF Receptor Targeted Therapy of Human Leukemia, Arthur E. Frankel, Philip D. Hall, Dongsun Cao, Tie Fu Liu, Marlena Moors, Kimberley A. Cohen, Andrew M. Thorburn, and Robert J. Kreitman VEGF-diphtheria toxin for Targeting of Tumor Blood Vessels, Indira V. Subramanian, and Sundaram Ramakrishnan PART 4. MISCELLANEOUS cBR-96-doxorubicin (SGN-15) for Metastatic Breast Cancer Therapy, Lisle Nabell, Clay B. Siegall, and Mansoor N. Saleh Anti-CD33 Calicheamicin Immunoconjugate Therapy of Acute Myeloid Leukemia, Charalambos Andreadis, Selina M. Luger Selina, and Edward A. Stadtmauer
{{comment.content}}